IDiyas

For the Inventor, By the Inventor

Harlow, United Kingdom

Amanda Johns

USPTO Granted Patents = 18

Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 90(Granted Patents)


Location History:

  • Bishop's Stortford, GB (2001 - 2002)
  • St Albans, GB (2000 - 2004)
  • Harlow, GB (2006 - 2011)

Company Filing History:

goldMedal18 out of 2,198 
 
Smithkline Beecham Corporation
 patents

Years Active: 2000-2011

Loading Chart...
18 patents (USPTO):Explore Patents
1. 7943645 - Piperidine compounds for use as orexin receptor antagonist (2011-05-17),
2. 7928125 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2011-04-19),
3. 7928124 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2011-04-19),
4. 7919507 - N-aroyl cyclic amines (2011-04-05),
5. 7897618 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2011-03-01),
6. 7893090 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2011-02-22),
7. 7741329 - N-aroyl cyclic amines (2010-06-22),
8. 7470710 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2008-12-30),
9. 7468367 - Ethylene diamine derivatives and their use as orexin-receptor antagonists (2008-12-23),
10. 7432270 - N-aroyl cyclic amines (2008-10-07),
11. 7423052 - Piperidine compounds for use as orexin receptor antagoinst (2008-09-09),
12. 7078565 - Benzamide derivatives as antagonists of orexin receptors (2006-07-18),
13. 6699879 - Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists (2004-03-02),
14. 6596730 - Phenyl urea and phenyl thiourea derivatives (2003-07-22),
15. 6410529 - Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists (2002-06-25),

Title: The Innovative Mind of Amanda Johns

Introduction: Amanda Johns, a prominent inventor based in Harlow, GB, has made significant contributions to the field of pharmaceuticals. With a total of 18 patents to her name, she has focused on developing compounds that address critical health issues.

Latest Patents: Among her latest innovations are two key patents involving piperidine compounds designed for use as orexin receptor antagonists. The inventions highlight N-aroyl cyclic amine derivatives and their potential applications in the pharmaceutical industry. These compounds showcase the intricate relationships between structure and function, offering new avenues for therapeutic intervention in sleep-related disorders.

Career Highlights: Amanda Johns has established herself as a valuable asset to her organization. Currently working at SmithKline Beecham Corporation, she has been involved in cutting-edge research and development initiatives that reflect her commitment to advancing healthcare solutions. Her inventive spirit is evident in her continuous pursuit of innovative methodologies to enhance pharmaceutical applications.

Collaborations: Throughout her career, Amanda has collaborated with esteemed colleagues, including Roderick Alan Porter and Geoffrey Stemp. These partnerships have enriched her research endeavors, allowing for a cross-pollination of ideas and expertise that has propelled her inventions to new heights.

Conclusion: Amanda Johns exemplifies the dedication and creativity of leading inventors in the pharmaceutical industry. With a robust portfolio of patents and strategic collaborations, she continues to push the boundaries of innovation, making a lasting impact on healthcare and the science of therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…